Quote For Osiris Therapeutics Inc
Osiris Therapeutics Inc (OSIR.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare ·
industry: Biotechnology ·
$6.50
25 Nov 2009
-0.31%
$6.50
--
88,465
$6.56
$6.48
$21.65
$5.35
0.62
118,861
News
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Friedli, Peter | Chairman of the Board | -- |
| Mills, C. Randall | President, Chief Executive Officer, Director | 1,215,917 |
| Jacoby, Philip | Chief Financial Officer, Vice President - Finance, PAO, Corporate Secretary | 204,106 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $212.94 |
| Shares Outstanding (Mil.) | 32.76 |
| Float (Mil.) | 17.80 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 2.21 |
| Current Ratio | 2.08 |
| LT Debt/Equity | 94.22 |
| Total Debt/Equity | 94.46 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 7.02 |
| Price/Book(TTM) | 72.85 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-1.50 |
| Sales(TTM) | $0.94 |
| Book Value(MRQ) | $0.09 |
| Cash Flow(TTM) | $-1.46 |
| Cash(MRQ) | $1.59 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -- |
| Return on Assets(TTM) | -59.76 |
| Return on Investment(TTM) | -168.11 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | -- |
| Operating Margin(TTM) % | -165.90 |
| Profit Margin(TTM) % | -159.13 |
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 76.88 | -0.14% | 11/27 10:13 IST |
| Gold | 1185.8 | -0.59% | 11/27 09:52 IST |
